Dandelion root extracts and taraxasterol inhibit LPS‑induced colorectal cancer cell viability by blocking

Kerry Yang1, Yuehong Wang2,3

  • 1Faculty of Health Sciences, McMaster University, Hamilton, Ontario L8S 4L8, Canada.

Insights

Dandelion root extracts and taraxasterol (TS) show protective effects against colorectal cancer. These compounds reverse lipopolysaccharide (LPS)-induced cell viability by inhibiting key inflammatory pathways.

Area of Science:

  • Gastroenterology
  • Oncology
  • Microbiology

Background:

  • Colorectal cancer (CRC) is a leading cause of cancer death globally.
  • Intestinal bacteria and their products, like lipopolysaccharide (LPS), are implicated in CRC development.
  • Elevated LPS levels are observed in CRC patients, suggesting a role for bacterial endotoxins.

Purpose of the Study:

  • To investigate the protective effects of dandelion root extracts and taraxasterol (TS) on LPS-induced CRC cell viability.
  • To elucidate the underlying molecular mechanisms of action for dandelion extracts and TS.
  • To explore the role of TLR4/NFκB-p65 and ACE2/TMPRSS2 pathways in LPS-mediated CRC cell proliferation.

Main Methods:

  • Cell viability was assessed using MTT assays.
  • Protein and gene expression levels were determined via western blotting and quantitative PCR.
  • Specific pathway inhibitors (CLI095) and inflammatory cytokines (TNFα) were used to probe molecular mechanisms.

Main Results:

  • LPS (0.5 µg/ml) significantly promoted human colorectal cancer cell viability.
  • Dandelion root extracts (0.1-1 mg/ml) and TS (0.05-1 µg/ml) reversed LPS-induced increases in cell viability and colony formation.
  • Dandelion extracts/TS inhibited the LPS-promoted TLR4/NFκB-p65 pathway and pro-inflammatory gene expression, while reversing LPS-induced ACE2 and TMPRSS2 upregulation.

Conclusions:

  • Dandelion root extracts and TS demonstrate potential as preventative agents against bacteria-driven colorectal cancer.
  • These natural compounds may exert their effects by modulating the TLR4/NFκB-p65 signaling pathway and influencing ACE2/TMPRSS2 expression.
  • The findings suggest a therapeutic strategy involving dandelion-derived compounds for colorectal cancer prevention.

Related Concept Videos